Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable Stage I-II non-small-cell lung cancer. In reply to Dr. Xiao et al.

Cohen W. Hurkmans*, Johan P. Cuijpers, Frank J. Lagerwaard, Joachim Widder, Uulke A. van der Heide, Danny Schuring, Suresh Senan

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademic

Original languageEnglish
Pages (from-to)318-318
Number of pages1
JournalInternational journal of radiation oncology, biology, physics
Issue number1
Publication statusPublished - 1 Sep 2009

Cite this